NYSE - Delayed Quote USD

Clarivate Plc (CLVT)

7.12 +0.12 (+1.71%)
At close: April 26 at 4:00 PM EDT
7.12 0.00 (0.00%)
After hours: April 26 at 6:08 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jonathan Gear CEO & Director 1.9M -- 1971
Mr. Jonathan M. Collins Executive VP & CFO 1.31M -- 1980
Mr. Gordon Samson President of Intellectual Property 1.08M -- 1966
Mr. Bar Veinstein President of Academia & Government 1.1M -- 1973
Mr. Henry Levy President of Life Sciences & Healthcare 1.05M -- 1973
Mr. Michael Easton Senior VP of Finance & Chief Accounting Officer -- -- 1973
Mr. William E. Graff Executive VP & Chief Information Officer -- -- --
Mr. Mark J. Donohue Head of Investor Relations -- -- --
Ms. Melanie D. Margolin J.D. Chief Legal Officer & Secretary -- -- 1972
Ms. Tabita Andersson Senior Vice President of Communications & Brand -- -- --

Clarivate Plc

70 St. Mary Axe
London, EC3A 8BE
United Kingdom
44 20 7433 4000 https://www.clarivate.com
Sector: 
Technology
Full Time Employees: 
12,000

Description

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Corporate Governance

Clarivate Plc’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 10; Board: 1; Shareholder Rights: 3; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 08, 2024
Clarivate Plc Earnings Call

Related Tickers